Why Preventing Cancer Is Not the Priority in Drug Development

Biotechin.Asia

Why most of the research focuses on treating cancer rather than preventing it?

This is because the economic resources motivate researchers to focus on treatment rather than prevention. More profits have been made, investing in medication that extends the lives of cancer patients by even a few months rather than investing in medicines that would altogether prevent the development of cancer.

29up-healthincent2-master675 bit.ly/1WCjt5m

R&D on cancer prevention and treatment of early-stage cancer is very socially valuable, but developing drugs to treat late-stage disease is usually much faster than developing drugs to treat early-stage disease or prevention. This is because late-stage disease is aggressive and progresses rapidly. This allows companies to see results in clinical trials more quickly, even if those results are only in the form of small improvements in survival.

Drug manufacturers always rush through their product to be safe and effective, so they get patent(s) for the drug and approval from FDA…

View original post 282 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s